Carta Revisado por pares

The metabolic syndrome—is one global definition possible?

2004; Wiley; Volume: 21; Issue: 10 Linguagem: Inglês

10.1111/j.1464-5491.2004.01400.x

ISSN

1464-5491

Autores

Marit E. Jørgensen, Knut Borch‐Johnsen,

Tópico(s)

Metabolism, Diabetes, and Cancer

Resumo

Diabetic MedicineVolume 21, Issue 10 p. 1064-1065 The metabolic syndrome—is one global definition possible? Marit Eika Jørgensen, Marit Eika Jørgensen National Public Health Institute, Section for Research in Greenland, Copenhagen, andSearch for more papers by this authorKnut Borch-Johnsen, Knut Borch-Johnsen Steno Diabetes Centre, Gentofte, Denmark National Public Health Institute, Section for Research in Greenland, Copenhagen, andSearch for more papers by this author Marit Eika Jørgensen, Marit Eika Jørgensen National Public Health Institute, Section for Research in Greenland, Copenhagen, andSearch for more papers by this authorKnut Borch-Johnsen, Knut Borch-Johnsen Steno Diabetes Centre, Gentofte, Denmark National Public Health Institute, Section for Research in Greenland, Copenhagen, andSearch for more papers by this author First published: 22 September 2004 https://doi.org/10.1111/j.1464-5491.2004.01400.xCitations: 16Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595– 1607. 2 Kim ES, Han S-M, Kim YI, Song K-H, Kim M-S, Kim WB et al. Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea. Diabet Med 2004; 21: 1141– 1143. 3 Song J, Kim E, Shin C, Kim S-S, Lee HK, Jung M et al. Prevalence of the metabolic syndrome among South Korean adults: the Ansan study. Diabet Med 2004; 21: 1154– 1155. 4 Valdez R, Gonzalez-Villalpando C, Mitchell BD, Haffner SM, Stern MP. Differential impact of obesity in related populations. Obes Res 1995; 3: 223s– 232s. 5 Lackland DT, Orchard TJ, Keil JE, Saunders DE, Wheeler FC, Adams-Campbell LL et al. Are race differences in the prevalence of hypertension explained by body mass and fat distribution? A survey in a biracial population. Int J Epidemiol 1992; 21: 236– 245. 6 Jorgensen ME, Glumer C, Bjerregaard P, Gyntelberg F, Jorgensen T, Borch-Johnsen K. Obesity and central fat pattern among Greenland Inuit and a general population of Denmark (Inter99): relationship to metabolic risk factors. Int J Obes Relat Metab Disord 2003; 27: 1507– 1515. 7 Choo V. WHO reassesses appropriate body-mass index for Asian populations. Lancet 2002; 360: 235. 8 Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575– 581. 9 Meigs JB, Wilson PW, Nathan DM, D’Agostino RB, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003; 52: 2160– 2167. 10 Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683– 689. 11 Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709– 2716. 12 Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American indians: the strong heart study. Diabetes Care 2003; 26: 861– 867. 13 Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356– 362. 14 Thomsen TF, Davidsen M, Ibsen H, Jorgensen T, Jensen G, Borch-Johnsen K. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. J Cardiovasc Risk 2001; 8: 291– 297. Citing Literature Volume21, Issue10October 2004Pages 1064-1065 ReferencesRelatedInformation

Referência(s)
Altmetric
PlumX